131 related articles for article (PubMed ID: 3427414)
21. Regional effects of neurotensin on the electrically stimulated release of [3H]dopamine and [14C]acetylcholine in the rat nucleus accumbens.
Reyneke L; Russell VA; Taljaard JJ
Neurochem Res; 1992 Nov; 17(11):1143-6. PubMed ID: 1461361
[TBL] [Abstract][Full Text] [Related]
22. [Regulation of 3H-dopamine release by presynaptic GABA and glutamate heteroreceptors in the synaptosomes of the rat nucleus accumbens].
Kovalev GI; Hetey L
Biull Eksp Biol Med; 1987 Jan; 103(1):75-8. PubMed ID: 3026521
[TBL] [Abstract][Full Text] [Related]
23. Effect of chronic antidepressant treatment on noradrenergic modulation of [3H]dopamine release from rat nucleus accumbens and striatal slices.
Russell VA; Nurse B; Lamm MC; Taljaard JJ
Brain Res; 1987 Apr; 410(1):78-82. PubMed ID: 3472627
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the synaptosomal high-affinity uptake of noradrenaline in the nucleus accumbens of rats.
Hetey L; Zimmermann B
Biomed Biochim Acta; 1986; 45(9):1203-7. PubMed ID: 3814110
[TBL] [Abstract][Full Text] [Related]
25. Neurotensin facilitates dopamine release in vitro from rat striatal slices.
de Quidt ME; Emson PC
Brain Res; 1983 Sep; 274(2):376-80. PubMed ID: 6626967
[TBL] [Abstract][Full Text] [Related]
26. The effects of cholecystokinin on the in vivo release of newly synthesized [3H]dopamine from the nucleus accumbens of the rat.
Voigt MM; Wang RY; Westfall TC
J Neurosci; 1985 Oct; 5(10):2744-9. PubMed ID: 4045551
[TBL] [Abstract][Full Text] [Related]
27. Neurotensin potentiates the potassium-induced release of endogenous dopamine from rat striatal slices.
Okuma Y; Fukuda Y; Osumi Y
Eur J Pharmacol; 1983 Sep; 93(1-2):27-33. PubMed ID: 6628546
[TBL] [Abstract][Full Text] [Related]
28. Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens.
Laitinen K; Crawley JN; Mefford IN; De Witte P
Brain Res; 1990 Jul; 523(2):342-6. PubMed ID: 1698106
[TBL] [Abstract][Full Text] [Related]
29. Thyrotrophin releasing hormone stimulates release of [3H]-dopamine from slices of rat nucleus accumbens in vitro.
Kerwin RW; Pycock CJ
Br J Pharmacol; 1979 Nov; 67(3):323-5. PubMed ID: 115532
[TBL] [Abstract][Full Text] [Related]
30. Mazindol, nomifensine and desmethylimipramine inhibit potassium-induced release of dopamine: effect of stimulus strength.
Dembiec-Cohen D
J Neural Transm (Vienna); 1998; 105(6-7):735-47. PubMed ID: 9826115
[TBL] [Abstract][Full Text] [Related]
31. B-HT 920 and B-HT 958: presynaptic effects on electrically evoked 3H-dopamine release from slices of rat nucleus accumbens.
Cichini G; Placheta P; Singer EA
Naunyn Schmiedebergs Arch Pharmacol; 1987 Jan; 335(1):28-31. PubMed ID: 2883584
[TBL] [Abstract][Full Text] [Related]
32. The effect of uptake inhibition on dopamine release from the nucleus accumbens of rats during self- or forced stimulation of the medial forebrain bundle: a microdialysis study.
Nakahara D; Ozaki N; Kapoor V; Nagatsu T
Neurosci Lett; 1989 Sep; 104(1-2):136-40. PubMed ID: 2812526
[TBL] [Abstract][Full Text] [Related]
33. Effects of chronic nicotine pretreatment on (+)-amphetamine and nicotine-induced synthesis and release of [3H]dopamine from [3H]tyrosine in rat nucleus accumbens.
Fung YK
J Pharm Pharmacol; 1989 Jan; 41(1):66-8. PubMed ID: 2565971
[TBL] [Abstract][Full Text] [Related]
34. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol.
Imperato A; Di Chiara G
J Pharmacol Exp Ther; 1986 Oct; 239(1):219-28. PubMed ID: 3761194
[TBL] [Abstract][Full Text] [Related]
35. Chronic desipramine enhances the effect of locally applied amphetamine on interstitial concentrations of dopamine in the nucleus accumbens.
Brown EE; Nomikos GG; Wilson C; Fibiger HC
Eur J Pharmacol; 1991 Sep; 202(1):125-7. PubMed ID: 1786799
[TBL] [Abstract][Full Text] [Related]
36. In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens.
Lane RF; Blaha CD; Phillips AG
Brain Res; 1986 Nov; 397(1):200-4. PubMed ID: 3801862
[TBL] [Abstract][Full Text] [Related]
37. Reversal by cholecystokinin of apomorphine-induced inhibition of dopamine release in the nucleus accumbens of the rat.
Blaha CD; Phillips AG; Lane RF
Regul Pept; 1987 Jun; 17(6):301-10. PubMed ID: 3602473
[TBL] [Abstract][Full Text] [Related]
38. Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminals.
Hoffmann IS; Talmaciu RK; Ferro CP; Cubeddu LX
J Pharmacol Exp Ther; 1988 Jun; 245(3):761-72. PubMed ID: 3385641
[TBL] [Abstract][Full Text] [Related]
39. Effects of ion channel blockers and phorbol ester treatments on [3H]dopamine release and neurotensin facilitation of [3H]dopamine release from rat mesencephalic cells in primary culture.
Brouard A; Pelaprat D; Vial M; Lhiaubet AM; Rostène W
J Neurochem; 1994 Apr; 62(4):1416-25. PubMed ID: 7510781
[TBL] [Abstract][Full Text] [Related]
40. Dopamine release in the nucleus accumbens of freely moving rats determined by on-line dialysis: effects of apomorphine and the neuroleptic-like peptide desenkephalin-gamma-endorphin.
Radhakishun FS; Westerink BH; van Ree JM
Neurosci Lett; 1988 Jul; 89(3):328-34. PubMed ID: 2901702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
